Caliper Teams with Horizon on Oncology Cell Lines

Apr 09, 2008

NEW YORK (GenomeWeb News) – Caliper Life Sciences today announced that it is incorporating Horizon Discovery’s oncology cell lines into its offerings from Caliper Discovery Alliances and Services.

According to Hopkinton, Mass.-based Caliper, the deal provides CDAS with unique, genetically defined, and isogenic human cancer cell lines that will enable researchers to better identify and characterize personalized drugs targeted at specific subsets of patients.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

A Winning Diagnostic

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

Science in Africa Unevenly Funded

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

Not Enough Progress?

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

This Week in Science

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.

Main menu